These are the source articles connected to the rhythm summaries.
Revvity (RVTY) Valuation Check After China Immunodiagnostics Exit Plan And Solid First Quarter Results
Source: Yahoo • Published: 2026-06-08
NeutralRevvity (RVTY) is back in focus after announcing plans to divest its China immunodiagnostics business, a unit facing policy and cash flow headwinds, alongside reporting solid first quarter revenue and margin figures. See our latest analysis for Revvity. The stock has given up some ground in the past week, with a 1-day share price decline of 3.94% and a 7-day share price return of 2.14% lower. However, the 90-day share price return is up 8.94% and the 1-year total shareholder return is 6.21%,...
View original source →Why Is Revvity (RVTY) Up 2% Since Last Earnings Report?
Source: Yahoo • Published: 2026-06-04
NeutralRevvity (RVTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
View original source →Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers
Source: Yahoo • Published: 2026-06-01
NeutralAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at research tools & consumables stocks, starting with Revvity (NYSE:RVTY).